A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

12/1/2005 P R Health Sci J. 2005 Dec;24(4):269-76 Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. Case studies suggest that vitamin C, given intravenously at doses of 10-100 grams/day can improve patient well being and in some cases, reduce tumor size. While ascorbate is generally considered safe, clinical data…

The Stem Cell Institute has integrated Intranasal MTF Therapy into its autism protocol:

  • MTF therapy features exosomes and over 300 beneficial molecules
  • Works in synergy with our stem cells
  • Offers anti-inflammatory and regenerative effects
  • Delivered in an easy-to-administer aerosol format via the nose
  • To discover more about MTF and its benefits, click here